Circulating procoagulant microparticles in cancer patients
- 462 Downloads
Accumulating evidence indicates that microparticles (MPs) are important mediators of the interaction between cancer and the hemostatic system. We conducted a large prospective cohort study to determine whether the number of circulating procoagulant MPs is elevated in cancer patients and whether the elevated MP levels are predictive of occurrence of venous thrombembolism (VTE). We analyzed plasma samples of 728 cancer patients from the ongoing prospective observational Vienna Cancer and Thrombosis Study. Study endpoint was the occurrence of symptomatic VTE. Sixty-five age- and sex-matched healthy controls were recruited for defining the cut-off point for elevated MPs (4.62 nanomolar phosphatidylserine [nM PS]), which was set at the 95th percentile of MP levels in healthy controls. The measurement of MPs was performed after capture onto immobilized annexin V, and determination of their procoagulant activity was quantified with a prothrombinase assay. During a median observation period of 710 days, 53 patients developed VTE. MP levels (nM PS) were significantly higher in cancer patients than in healthy controls (median [25th–75th percentile], 3.95 [1.74–7.96] vs. 1.19 [0.81–1.67], p < 0.001). Multivariate analysis including age, sex, surgery, chemo- and radiotherapy showed no statistically significant association of the hazard ratio of elevated MPs with VTE (0.95 [95% CI, 0.55–1.64], p = 0.856). In conclusion, MP levels were elevated in cancer patients compared to healthy individuals in this study. However, elevated MP levels were not predictive of VTE.
KeywordsMicroparticles Cancer Venous thromboembolism Prothrombinase assay
Cancer and Thrombosis Study
- nM PS
Nanomolar phosphatidylserine equivalent
P-selectin glycoprotein ligand
We thank all persons that supported us in patient recruitment for the Vienna Cancer and Thrombosis Study (CATS), Silvia Koder for skillful technical assistance, and Tanja Altreiter for proof-reading of the manuscript.
This study was supported by grants from the “Jubiläumsfonds” of the Austrian National Bank, by an unrestricted grant from Pfizer Austria, and the “Fellinger Krebsforschung”.
- 1.Siljander P, Carpen O, Lassila R (1996) Platelet-derived microparticles associate with fibrin during thrombosis. Blood 87I:4651–4663Google Scholar
- 6.Schecter AD, Spirn B, Rossikhina M et al (2000) Release of active tissue factor by human arterial smooth muscle cells. Circ Res 87I:126–132Google Scholar
- 7.Hugel B, Martinez MC, Kunzelmann C et al (2005) Membrane microparticles: two sides of the coin. Physiology (Bethesda) 20I:22–27Google Scholar
- 18.Sousou T, Khorana A (2009) Identifying cancer patients at risk for venous thromboembolism. Hamostaseologie 29I:121–124Google Scholar
- 19.Toth B, Liebhardt S, Steinig K et al (2008) Platelet-derived microparticles and coagulation activation in breast cancer patients. Thromb Haemost 100I:663–669Google Scholar
- 22.Langer F, Spath B, Haubold K, Holstein K, Marx G, Wierecky J, Brümmendorf TH, Dierlamm J, Bokemeyer C, Eifrig B (2008) Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation. Ann Hematol 87I:451–457CrossRefGoogle Scholar
- 29.Hron G, Kollars M, Weber H et al (2007) Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 97I:119–123Google Scholar
- 33.Semrad TJ, O’Donnell R, Wun T et al (2007) Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg 106I:601–608Google Scholar
- 39.Nieuwland R, Berckmans RJ, McGregor S et al (2000) Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95I:930–935Google Scholar
- 41.Mallat Z, Benamer H, Hugel B et al (2000) Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101I:841–843Google Scholar
- 42.Manly DA, Wang J, Glover SL et al (2009) Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thromb Res 125I:511–512Google Scholar